Progression of Antisense Oligonucleotide Gapmers for the Treatment of Huntingtons Ailment: Revision history

Jump to: navigation, search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

29 January 2024

  • curprev 09:2609:26, 29 January 2024Planevein7 talk contribs 3,474 bytes +3,474 Created page with "We wanted to look at regardless of whether censoring patterns differ involving the management and new hands in one oncology record that requires the actual reporting with the amount of patients censored. Within this retrospective evaluate, amount of censoring and study design and style information had been accumulated coming from RCTs posted from the Lancet Oncology which described Kaplan-Meier shapes in between May well 2018 and July 2019. Differential censoring charges..."